BTSDF Stock Chart & Stats
$1.59
$0.00(0.00%)
At close: 4:00 PM EST
$1.59
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.00 - $1.92
Previous CloseN/A
Volume85.00
Average Volume (3M)15.00
Market Cap
$1.20B
Enterprise Value$16.63K
Total Cash (Recent Filing)$1.73B
Total Debt (Recent Filing)$9.06B
Price to Earnings (P/E)41.9
Beta-0.38
Next Earnings
Aug 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.11%
Share Statistics
EPS (TTM)0.30
Shares Outstanding645,561,340
10 Day Avg. Volume0
30 Day Avg. Volume15
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.26
Price to Sales (P/S)0.53
P/FCF Ratio7.98
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$2.53Price Target Upside58.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.16
Revenue Forecast (FY)$2.10B
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins around 60–64% indicate durable product-level economics and pricing power in branded nutrition. High gross margins provide a structural cushion against input cost swings and support long-term reinvestment in marketing and new SKUs, improving resilience over months.
Consistent Free Cash FlowMaterial, consistently positive free cash flow (~HK$0.95B in 2025) underpins operational self-sufficiency, funds working capital, and can finance product development or selective deleveraging. Reliable cash generation is a durable strength for funding strategy without sole reliance on external capital.
Multi-channel Branded ModelA diversified go-to-market mix (own e-commerce, third-party online, pharmacies, specialty retailers, distributors) and branded product focus reduce concentration risk, support stable demand, and enable channel-led margin optimization—advantages that persist over medium term.
Bears Say
Elevated LeverageStructural leverage at ~1.5x equity reduces financial flexibility and raises refinancing and interest risk. With elevated debt levels, the company is more exposed to earnings shocks and has less maneuverability to fund growth or absorb cost inflation without extending maturities or cutting investment.
Volatile Profitability And Weak ROEEarnings volatility and a collapse in ROE from prior highs signal fragile bottom-line performance. Intermittent losses and thin net margins limit retained earnings, constrain capacity to compound equity, and make planning for multi-quarter investments or debt paydown more uncertain.
Slowing Cash Flow Growth And Low CoverageA meaningful decline in FCF (-20.6% in 2025) and low operating-cash-to-debt coverage (~0.22) reduce the company's capacity to rapidly deleverage or expand capex. This constrains strategic flexibility and prolongs reliance on existing financing structures over months.
Health and Happiness (H&H) International Holdings News
BTSDF FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was $1.00 and its highest was $1.92 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is $1.20B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Aug 25, 2026 which is in 30 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Mar 24, 2026. The company reported $0.027 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited pays a Quarterly dividend of $0.02 which represents an annual dividend yield of 3.11%. See more information on Health and Happiness (H&H) International Holdings Limited dividends here
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of $0.027 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in BTSDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health and Happiness (H&H) International Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.53 (58.96% Upside)
$2.53 (58.96% Upside)
Blogger Sentiment
Bullish
BTSDF Sentiment 100%
Sector Average 61%
Sector Average 61%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.69%
12-Months-Change
Fundamentals
Return on Equity
3.11%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Company Description
Health and Happiness (H&H) International Holdings Limited
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (BTSDF) Earnings & Revenues
BTSDF Stock 12 Month Forecast
Average Price Target
$2.53
▲(58.96% Upside)
Technical Analysis
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―
Ownership Overview
―
Insiders
1.55% Mutual Funds
<0.01% Other Institutional Investors
96.55% Public Companies and
Individual Investors






